Stay updated with breaking news from Yuling Luo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Strategic partnership expands Biognosys’ services to include Alamar’s NULISA assays as well as joint scientific research in biofluid-based proteomicsComplementary value of Biognosys’ DIA-MS unbiased proteomics platform and Alamar’s game-changing immunoassay platforms to be presented at...
/PRNewswire/ -- Biognosys, a global leader in mass spectrometry-based proteomics, and Alamar Biosciences, Inc., a company powering precision proteomics to...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Alamar Biosciences, a leader in precision proteomics for early disease detection raises $100M in Series C round, with an additional $28M...
/PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced today the first publication...